Trailing-twelve-month (TTM) revenue is $1.10 Billion with a year-over-year growth of +37.90%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $229,039,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $289,323,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $285,364,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $297,984,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $1,101,710,000 |
Current P/S: $1,398,622,329 market capitalization ÷ $1,101,710,000 TTM revenue = 1.27x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:55:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $297.98M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:58:17.256Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Home Health And Hospice Services Segment | $254M | $310M | $342M | $394M | $515M | $731M |
| Senior Living Services Segment | $137M | $130M | $131M |
$1.10B
$1.10 Billion
+37.90%
vs. $798.92M a year ago (TTM)
+21.14%
5 Year compound annual growth rate
1 Year
+37.90%
3 Year
+29.97%
5 Year
+21.14%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $947.71M | +$252.47M | +36.31% |
| 2024 | $695.24M | +$150.35M | +27.59% |
| 2023 | $544.89M | +$71.65M | +15.14% |
| 2022 | $473.24M | +$33.55M | +7.63% |
| 2021 | $439.69M | +$48.74M | +12.47% |
| 2020 |
TTM Growth
+37.90%
3-Year CAGR
+29.97%
5-Year CAGR
+21.14%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:58:17.256Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $150M |
| $176M |
| $215M |
| $390.95M |
| +$52.42M |
| +15.49% |
| 2019 | $338.53M | +$52.47M | +18.34% |
| 2018 | $286.06M | +$35.07M | +13.97% |
| 2017 | $250.99M | +$33.77M | +15.54% |
